Medication info
Telcatan 80 mg (Telmisartan)

Telcatan 80 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tablet
Manufacturer / importer
Korean Pharmbio Co., Ltd.
Appearance
White oval-shaped tablet
Packaging
30 tablets/box [(10 tablets/Alu-Alu x 3)], 30 tablets/bottle
Approval status
Active

MFDS item code 201005025 · Approved 2010.08.16 · Insurance code 659900470

Summary

Main use
Treatment of essential hypertension; reduction of cardiovascular disease risk
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken regardless of meals. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. Following a dose increase, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after initiation of treatment. This medicine produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at 80 mg once daily with water and may be taken regardless of meals. The effect of doses below 80 mg in reducing the risk of cardiovascular morbidity and mortality is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medicines may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Korean Pharmbio Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; reduction of cardiovascular disease risk

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attacks
  • high-risk diabetes with clinical signs of end-organ damage
  • myocardial infarction
View approved original text

This medication is used to treat essential hypertension, helping to control blood pressure and reduce the risk of cardiovascular diseases. It can be given as an alternative medication when ACE inhibitors cannot be used. It is useful in high-risk diabetic patients aged over 55 who have a history of coronary artery disease, peripheral artery disease, stroke, or transient ischemic attacks, or have damage to end organs, in reducing the risk of myocardial infarction, stroke, and death due to cardiovascular diseases. Therefore, this medication is effectively used not only for blood pressure management but also for the prevention and risk reduction of cardiovascular diseases.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken regardless of meals. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. Following a dose increase, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after initiation of treatment. This medicine produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at 80 mg once daily with water and may be taken regardless of meals. The effect of doses below 80 mg in reducing the risk of cardiovascular morbidity and mortality is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medicines may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm to the fetus and newborn, especially during pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Patients with a known allergy to this medication, pregnant or breastfeeding women, patients with severe liver dysfunction or bile obstruction, hereditary angioedema patients, and patients with diabetes or severe kidney dysfunction should not take this medication. Elderly patients, those with hyperkalemia, liver disorders, heart valve diseases, ischemic heart disease, gastrointestinal disorders, renal artery hypertension, and severe kidney disorders should use this medication with caution. Various adverse reactions may occur while taking this medication, and patients should consult a healthcare professional immediately if they experience significantly low blood pressure, hyperkalemia, renal dysfunction, angioedema, liver abnormalities, interstitial lung disease, or rhabdomyolysis. Patients with impaired renal function should regularly check their serum potassium and creatinine levels, and correct their blood volume and sodium status in advance if they are at risk of hypotension. This medication can enhance the blood pressure-lowering effect when used with other antihypertensive agents, so caution is required. Particularly, the risk of side effects may increase when used concurrently with other RAAS agents, potassium-sparing diuretics, NSAIDs, lithium, etc., so it is advisable to consult a doctor. It should never be taken during pregnancy, and it is also recommended to avoid taking it while breastfeeding. Safety and efficacy have not been established in children under 18 years, so it is not recommended. In elderly patients, this medication must be administered with caution due to the risk of excessive blood pressure lowering leading to stroke. In case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may appear, requiring immediate medical treatment. This medication should be kept out of reach of children and stored sealed until the time of administration.

Side effects

  • Upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 81 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver function abnormalities
  • hepatic impairment
  • hyperhidrosis
  • pruritus
  • rash
  • erythema
  • angioedema
  • drug eruption
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • lumbago
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute kidney failure
  • chest pain
  • asthenia
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • hemoglobin decrease
  • headache
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • decreased appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • shock
  • loss of consciousness
  • jaundice
  • anaphylaxis-like symptoms
  • interstitial pneumonia
  • rhabdomyolysis
  • palpitations
  • fatigue
  • nausea
  • inadequate effect
  • dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to avoid exposure to air and moisture. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius. This will help retain the medication's effectiveness and safety for an extended period.

Appearance and packaging

Appearance

White oval-shaped tablet

Package unit

30 tablets/box [(10 tablets/Alu-Alu x 3)], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.